Robert Carlisle is an Associate Professor in Biomedical Engineering and head of the Drug and Vaccine Delivery group within IBME. After completing a BSc in Biochemistry, an MSc in Toxicology and a PhD in Gene Delivery at Birmingham University, he worked for 8 years within the Department of Clinical Pharmacology and the Department of Oncology at the University of Oxford.
The majority of his work has been concerned with achieving systemic delivery of anti-cancer agents for the treatment of metastatic cancer. This has included the development and testing of novel nano-scale non-viral and viral gene delivery systems and liposomal agents for the delivery of conventional chemotherapeutics. Research within his labs covers the full scope of therapeutic design, formulation and testing with emphasis on how the specificity and efficacy of therapy can be improved.